401(k) · DOL Form 5500 · 2024

Pharmaceutical Research and Manufacturers of America 401(k) Plan

Data updated 2026-08-11

$126M
Total assets
227
Participants
92nd
Percentile by assets
$554,651
Avg per participant
PlainRetire home → About this data

Official DOL plan name: Pharmaceutical Research and Manufacturers of America Deferred Savings Plan · Sponsored by Pharmaceutical Research and Manufacturers of America · District of Columbia · Professional & Technical Services

$126M in assets, 227 participants

Pharmaceutical Research and Manufacturers of America's Pharmaceutical Research and Manufacturers of America Deferred Savings Plan reported $126M in total assets and 227 participants in its 2024 DOL Form 5500 filing, ranking in the 92nd percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • 92nd percentile by assets (of 123,622 plans)
  • #18,778 in Professional & Technical Services (20,173 peers)

Coverage in District of Columbia

Pharmaceutical Research and Manufacturers of America Deferred Savings Plan covers 227 participants in District of Columbia, about 16% of the average District of Columbia filer (state average ~1,456 per filing). Assets: $126M.

$126M
total plan assets (2024 EOY)
227
covered participants
92nd
percentile by assets (of 123,622 plans)
$554,651
avg assets per participant

Where Pharmaceutical Research and Manufacturers of America Deferred Savings Plan sits by total assets

Pharmaceutical Research and Manufacturers of America Deferred Savings Plan vs every filed plan by assets

End-of-year total assets · plan year 2024 · DOL Form 5500

$125,905,769 Top 8% higher than 92% of 123,620 filed plans

This plan $0 $2,010,000,000 every filed plan with reported assets, bucketed by value

Dashed line + filled bar = this entry, among filed plans.

Source U.S. Department of Labor Form 5500 filings (EBSA) · plan year 2024

What changed between DOL Form 5500 filings

plan year 2023 → plan year 2024

  • Pharmaceutical Research and Manufacturers of America Deferred Savings Plan reported net income fell from $17M in the plan year 2023 filing to $14M in the plan year 2024 filing.
  • Pharmaceutical Research and Manufacturers of America Deferred Savings Plan end-of-year assets rose from $112M in the plan year 2023 filing to $126M in the plan year 2024 filing.
  • Pharmaceutical Research and Manufacturers of America Deferred Savings Plan reported participants fell from 243 in the plan year 2023 filing to 227 in the plan year 2024 filing.

See the national 2023→2024 release diff →

Participants vs District of Columbia filers

In District of Columbia, the average filing covers about 1,456 participants across 881 plans. Pharmaceutical Research and Manufacturers of America Deferred Savings Plan reports 227 participants - about 16% of that state average ($126M EOY assets).

District of Columbia filing particulars

Total Assets (Beginning of Year)$112M
Net Assets (End of Year)$126M
Net Income$14M
Employer EIN530241211
Plan Effective Date1986-01-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Pharmaceutical Research and Manufacturers of America)

$90M$100M$110M$120M$130M 202220232024 $95.1M $126M ▲ +32.4%
Total plan assets by year, all Pharmaceutical Research and Manufacturers of America plans on file
Year Plans Participants Total Assets
2022 2 312 $95M
2023 1 243 $112M
2024 1 227 $126M

Nearby 401(k) Plans in District of Columbia

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Pharmaceutical Research and Manufacturers of America Deferred Savings Plan vs. nearby 401(k) plans in District of Columbia, assets vs. participants

Pharmaceutical Research and Manufacturers of America Deferred Savings Plan vs. nearby 401(k) plans in District of Columbia, assets vs. participants Scatter plot of 6 data points. -10000010000200003000040000 -202468 Total assets ($B) Participants Pharmaceutical Resea…Danaher Corporation …Geico 401(k) Savings…Federal National Mor…Finra Savings Plus P…Hogan Lovells US LLP…
Pharmaceutical Research and Manufacturers of America Deferred Savings Plan vs. nearby 401(k) plans in District of Columbia, assets vs. participants

Similar-Sized 401(k) Plans Nationally

401(k) plans in other states closest to Pharmaceutical Research and Manufacturers of America Deferred Savings Plan by total assets, not by location.

Frequently Asked Questions

How did Pharmaceutical Research and Manufacturers of America Deferred Savings Plan assets move in 2024?
Pharmaceutical Research and Manufacturers of America Deferred Savings Plan grew at a solid clip - up 12.7% during 2024, from $112M to $126M. Reported net income was $14M.
How have Pharmaceutical Research and Manufacturers of America plan assets changed over time?
Across 3 plan years on file (2022-2024), Pharmaceutical Research and Manufacturers of America's sponsor-wide assets grew 32.4%, from $95M to $126M.
Where does Pharmaceutical Research and Manufacturers of America Deferred Savings Plan rank by assets among Form 5500 filers?
Pharmaceutical Research and Manufacturers of America Deferred Savings Plan ranks in the 92nd percentile by end-of-year assets among 123,622 plans that reported assets for plan year 2024 (in the top 10% of all filed plans by assets).
Which 401(k) plans are similar in size to Pharmaceutical Research and Manufacturers of America Deferred Savings Plan?
Among 401(k) plans in other states, the closest by assets is Lectra USA 401(k) Plan in CT ($126M, 345 participants).

Filing takeaways

Ways to act on Pharmaceutical Research and Manufacturers of America Deferred Savings Plan's numbers.